Page last updated: 2024-10-26

econazole and Abnormalities, Drug-Induced

econazole has been researched along with Abnormalities, Drug-Induced in 1 studies

Econazole: An imidazole derivative that is commonly used as a topical antifungal agent.
econazole : A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.
1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group.

Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Research Excerpts

ExcerptRelevanceReference
"To study human risk and benefit of vaginal econazole treatment during pregnancy."7.72A population-based case-control teratological study of vaginal econazole treatment during pregnancy. ( Czeizel, AE; Kazy, Z; Vargha, P, 2003)
"To study human risk and benefit of vaginal econazole treatment during pregnancy."3.72A population-based case-control teratological study of vaginal econazole treatment during pregnancy. ( Czeizel, AE; Kazy, Z; Vargha, P, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czeizel, AE1
Kazy, Z1
Vargha, P1

Other Studies

1 other study available for econazole and Abnormalities, Drug-Induced

ArticleYear
A population-based case-control teratological study of vaginal econazole treatment during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2003, Dec-10, Volume: 111, Issue:2

    Topics: Abnormalities, Drug-Induced; Administration, Intravaginal; Antifungal Agents; Birth Weight; Case-Con

2003